• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素1受体拮抗剂可抑制人黑色素瘤/裸鼠系统中由白细胞介素1或脂多糖诱导的转移增强。

Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.

作者信息

Chirivi R G, Garofalo A, Padura I M, Mantovani A, Giavazzi R

机构信息

Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

出版信息

Cancer Res. 1993 Oct 15;53(20):5051-4.

PMID:8267795
Abstract

This study examined the ability of the recombinant human interleukin 1 receptor antagonist (IL-1ra) to block interleukin 1 (IL-1)-mediated experimental metastases from the A375M human melanoma. In vivo, IL-1ra administrated at concentrations > or = 200 times IL-1 significantly inhibited the increase in lung colonies induced by IL-1 in nude mice. The response to IL-1 was significantly inhibited when IL-1ra was administered simultaneously with or 1 to 3 h before IL-1. In vitro, the incubation of IL-1-activated endothelial cells with IL-1ra prevented the increase in adhesion of A375M melanoma cells. At the same experimental conditions, IL-1ra inhibited the augmented expression of the intracellular and vascular cell adhesion molecules 1 and E-selectin induced by IL-1 on endothelial cells. Lipopolysaccharide, an IL-1 inducer, increased the number of lung colonies in nude mice. IL-1ra injected with or 1 h after lipopolysaccharide inhibited this augmentation, suggesting a role for host-produced IL-1 in metastasis formation.

摘要

本研究检测了重组人白细胞介素1受体拮抗剂(IL-1ra)阻断白细胞介素1(IL-1)介导的A375M人黑色素瘤实验性转移的能力。在体内,以大于或等于IL-1浓度200倍的浓度给予IL-1ra可显著抑制裸鼠中由IL-1诱导的肺集落增加。当与IL-1同时或在IL-1之前1至3小时给予IL-1ra时,对IL-1的反应受到显著抑制。在体外,用IL-1ra孵育IL-1激活的内皮细胞可阻止A375M黑色素瘤细胞黏附增加。在相同实验条件下,IL-1ra抑制了IL-1诱导的内皮细胞上细胞内黏附分子1、血管细胞黏附分子1和E-选择素的表达增加。脂多糖作为一种IL-1诱导剂,增加了裸鼠肺集落的数量。与脂多糖同时或在脂多糖注射后1小时注射IL-1ra可抑制这种增加,提示宿主产生的IL-1在转移形成中起作用。

相似文献

1
Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.白细胞介素1受体拮抗剂可抑制人黑色素瘤/裸鼠系统中由白细胞介素1或脂多糖诱导的转移增强。
Cancer Res. 1993 Oct 15;53(20):5051-4.
2
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.白细胞介素1诱导人黑色素瘤在裸鼠体内实验性转移的增强。
Cancer Res. 1990 Aug 1;50(15):4771-5.
3
Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.晚期抗原4整合素在白细胞介素1增强的黑色素瘤实验性转移中的作用。
Cancer Res. 1995 Jan 15;55(2):414-9.
4
Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.白细胞介素1受体拮抗剂基因转导对裸鼠人黑色素瘤异种移植瘤的影响。
Cancer Res. 2003 Sep 15;63(18):5957-61.
5
Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.白细胞介素10抑制人黑色素瘤细胞的肿瘤生长和转移:对血管生成的潜在抑制作用。
Clin Cancer Res. 1996 Dec;2(12):1969-79.
6
FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.FCE 27266,一种磺酸基双氢霉素衍生物,可抑制实验性和自发性肺及肝转移。
Invasion Metastasis. 1995;15(5-6):222-31.
7
Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases.白细胞介素-1受体阻断可减少小鼠B16黑色素瘤肝转移灶的数量和大小。
Cancer Res. 1994 May 15;54(10):2667-72.
8
Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.白细胞介素-1受体拮抗剂可抑制体内皮下B16黑色素瘤的生长。
Anticancer Res. 1996 Jan-Feb;16(1):437-41.
9
Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.白细胞介素(IL)-2和IL-15在源自一名IL-2进展期患者的黑色素瘤细胞系MELP肿瘤进展中的作用。
Melanoma Res. 1997 Aug;7 Suppl 2:S7-17.
10
Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.从可生物降解微球持续释放白细胞介素-1受体拮抗剂可减少小鼠B16黑色素瘤肺转移灶的数量。
J Control Release. 2007 Nov 6;123(2):123-30. doi: 10.1016/j.jconrel.2007.07.015. Epub 2007 Aug 7.

引用本文的文献

1
IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer.肿瘤性疾病中的白细胞介素-1β及其肿瘤衍生形式在转移性前列腺癌进展和治疗中的作用。
Cancers (Basel). 2025 Jan 17;17(2):290. doi: 10.3390/cancers17020290.
2
Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.白细胞介素-1β对非小细胞肺癌中 PD-L1 表达的调控。
Front Immunol. 2023 Jun 27;14:1192861. doi: 10.3389/fimmu.2023.1192861. eCollection 2023.
3
Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas.
白细胞介素-1受体拮抗剂:一种对抗人类鳞状细胞癌的有前景的细胞因子。
Heliyon. 2023 Mar 28;9(4):e14960. doi: 10.1016/j.heliyon.2023.e14960. eCollection 2023 Apr.
4
Therapeutic yoga reduces pro-tumorigenic cytokines in cancer survivors.治疗性瑜伽可降低癌症幸存者的促肿瘤细胞因子。
Support Care Cancer. 2022 Dec 15;31(1):33. doi: 10.1007/s00520-022-07536-y.
5
Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs.比较 HPV 状态对人乳头瘤病毒相关头颈部鳞状细胞癌中白细胞介素-1 配体表达的影响。
Head Neck Pathol. 2022 Sep;16(3):763-772. doi: 10.1007/s12105-022-01440-x. Epub 2022 Mar 25.
6
Interleukin-1 receptor antagonist inhibits matastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer.白细胞介素-1 受体拮抗剂通过下调结直肠癌细胞中 CXCL12/CXCR4 信号轴抑制转移潜能。
Cell Commun Signal. 2021 Dec 20;19(1):122. doi: 10.1186/s12964-021-00804-0.
7
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma.循环细胞因子与转移性肾细胞癌系统治疗的临床反应相关。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-002009.
8
Therapeutic Strategies for Targeting IL-1 in Cancer.癌症中靶向白细胞介素-1的治疗策略
Cancers (Basel). 2021 Jan 26;13(3):477. doi: 10.3390/cancers13030477.
9
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity.白细胞介素-1 及其相关细胞因子在炎症和免疫调节中的作用。
Immunity. 2019 Apr 16;50(4):778-795. doi: 10.1016/j.immuni.2019.03.012.
10
Innate immunity, inflammation and tumour progression: double-edged swords.先天免疫、炎症与肿瘤进展:双刃剑。
J Intern Med. 2019 May;285(5):524-532. doi: 10.1111/joim.12886. Epub 2019 Mar 14.